{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:29:10Z","timestamp":1771482550593,"version":"3.50.1"},"reference-count":38,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,1,31]]},"DOI":"10.1536\/ihj.17-734","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T22:22:11Z","timestamp":1542666131000},"page":"151-158","source":"Crossref","is-referenced-by-count":16,"title":["Successful Inflammation Imaging of Non-Human Primate Hearts Using an Antibody Specific for Tenascin-C"],"prefix":"10.1536","volume":"60","author":[{"given":"Naohide","family":"Ageyama","sequence":"first","affiliation":[{"name":"Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"FUJIFILM RI Pharma Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousuke","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"FUJIFILM RI Pharma Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Radiotherapy, Chiba University Graduate School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Hiroe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Center for Global Health and Medicine"},{"name":"Mie University Research Center for Matrix Biology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Arano","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Radiotherapy, Chiba University Graduate School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Mie University Research Center for Matrix Biology"},{"name":"Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yasutomi","sequence":"additional","affiliation":[{"name":"Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Imanaka-Yoshida","sequence":"additional","affiliation":[{"name":"Mie University Research Center for Matrix Biology"},{"name":"Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Westman PC, Lipinski MJ, Luger D, <i>et al<\/i>. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2016; 67: 2050-60.","DOI":"10.1016\/j.jacc.2016.01.073"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 2014; 11: 255-65.","DOI":"10.1038\/nrcardio.2014.28"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kain V, Prabhu SD, Halade GV. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol 2014; 109: 444.","DOI":"10.1007\/s00395-014-0444-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Minamisawa M, Motoki H, Izawa A, <i>et al<\/i>. Comparison of inflammatory biomarkers in outpatients with prior myocardial infarction. Int Heart J 2016; 57: 11-7.","DOI":"10.1536\/ihj.15-197"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mao Y, Koga JI, Tokutome M, <i>et al<\/i>. Nanoparticle-mediated delivery of pitavastatin to monocytes\/macrophages inhibits left ventricular remodeling after acute myocardial infarction by inhibiting monocyte-mediated inflammation. Int Heart J 2017; 58: 615-23.","DOI":"10.1536\/ihj.16-457"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhang P, Shao L, Ma J. Toll-like receptors 2 and 4 predict new-onset atrial fibrillation in acute myocardial infarction patients. Int Heart J 2018; 59: 64-70.","DOI":"10.1536\/ihj.17-084"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002; 14: 608-16.","DOI":"10.1016\/S0955-0674(02)00361-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Murphy-Ullrich JE, Sage EH. Revisiting the matricellular concept. Matrix Biol 2014; 37: 1-14.","DOI":"10.1016\/j.matbio.2014.07.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Midwood KS, Chiquet M, Tucker RP, Orend G. Tenascin-C at a glance. J Cell Sci 2016; 129: 4321-7.","DOI":"10.1242\/jcs.190546"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Imanaka-Yoshida K. Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair. Circ J 2012; 76: 2513-20.","DOI":"10.1253\/circj.CJ-12-1033"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sato A, Aonuma K, Imanaka-Yoshida K, <i>et al<\/i>. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol 2006; 47: 2319-25.","DOI":"10.1016\/j.jacc.2006.03.033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sato A, Hiroe M, Akiyama D, <i>et al<\/i>. Prognostic value of serum tenascin-C levels on long-term outcome after acute myocardial infarction. J Card Fail 2012; 18: 480-6.","DOI":"10.1016\/j.cardfail.2012.02.009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nishikawa T, Sekiguchi M, Ishibashi-Ueda H. More than 50 years after Konno&apos;s development of the endomyocardial biopsy. Int Heart J 2017; 58: 840-6.","DOI":"10.1536\/ihj.16-316"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Imanaka-Yoshida K, Hiroe M, Yasutomi Y, <i>et al<\/i>. Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol 2002; 197: 388-94.","DOI":"10.1002\/path.1131"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sato M, Toyozaki T, Odaka K, <i>et al<\/i>. Detection of experimental autoimmune myocarditis in rats by <sup>111<\/sup>In monoclonal antibody specific for tenascin-C. Circulation 2002; 106: 1397-402.","DOI":"10.1161\/01.CIR.0000027823.07104.86"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Odaka K, Uehara T, Arano Y, <i>et al<\/i>. Noninvasive detection of cardiac repair after acute myocardial infarction in rats by <sup>111<\/sup>In Fab fragment of monoclonal antibody specific for tenascin-C. Int Heart J 2008; 49: 481-92.","DOI":"10.1536\/ihj.49.481"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Taki J, Wakabayashi H, Inaki A, <i>et al<\/i>. <sup>14<\/sup>C-methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion. J Nucl Med 2013; 54: 431-6.","DOI":"10.2967\/jnumed.112.112060"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Taki J, Inaki A, Wakabayashi H, <i>et al<\/i>. Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion. EJNMMI Res 2015; 5: 21.","DOI":"10.1186\/s13550-015-0100-8"},{"key":"19","unstructured":"19. Ageyama N, Hanazono Y, Shibata H, <i>et al<\/i>. Safe and efficient methods of autologous hematopoietic stem cell transplantation for biomedical research in cynomolgus monkeys. Comp Med 2002; 52: 445-51."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Honjo S. The Japanese Tsukuba Primate Center for Medical Science (TPC): an outline. 14: 1985: 75-89.","DOI":"10.1111\/j.1600-0684.1985.tb00173.x"},{"key":"21","unstructured":"21. National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals. <i>The National Academies Collection: Reports Funded by National Institutes of Health Guide for the Care and Use of Laboratory Animals<\/i>. 8th ed. Washington DC: National Academies Press (US); 2011."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yoshioka T, Ageyama N, Shibata H, <i>et al<\/i>. Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells 2005; 23: 355-64.","DOI":"10.1634\/stemcells.2004-0200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Arano Y, Uezono T, Akizawa H, <i>et al<\/i>. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative. J Med Chem 1996; 39: 3451-60.","DOI":"10.1021\/jm950949+"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mann DL. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res 2015; 116: 1254-68.","DOI":"10.1161\/CIRCRESAHA.116.302317"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. James OG, Christensen JD, Wong TZ, Borges-Neto S, Koweek LM. Utility of FDG PET\/CT in inflammatory cardiovascular disease. RadioGraphics 2011; 31: 1271-86.","DOI":"10.1148\/rg.315105222"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chareonthaitawee P, Beanlands RS, Chen W, <i>et al<\/i>. Joint SNMMI-ASNC expert consensus document on the role of <sup>18<\/sup>F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017; 58: 1341-53.","DOI":"10.2967\/jnumed.117.196287"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Morooka M, Kubota K, Kadowaki H, <i>et al<\/i>. <sup>11<\/sup>C-methionine PET of acute myocardial infarction. J Nucl Med 2009; 50: 1283-7.","DOI":"10.2967\/jnumed.108.061341"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Maya Y, Werner RA, Sch\u00fctz C, <i>et al<\/i>. <sup>11<\/sup>C-methionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis. J Nucl Med 2016; 57: 1985-90.","DOI":"10.2967\/jnumed.116.174045"},{"key":"29","unstructured":"29. Hung MY, Hung MJ, Cheng CW. Use of gallium 67 scintigraphy to differentiate acute myocarditis from acute myocardial infarction. Tex Heart Inst J 2007; 34: 305-9."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. de Haas HJ, Arbustini E, Fuster V, Kramer CM, Narula J. Molecular imaging of the cardiac extracellular matrix. Circ Res 2014; 114: 903-15.","DOI":"10.1161\/CIRCRESAHA.113.302680"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Jacobson O, Yan X, Niu G, <i>et al<\/i>. PET imaging of tenascin-C with a radiolabeled single-stranded DNA aptamer. J Nucl Med 2015; 56: 616-21.","DOI":"10.2967\/jnumed.114.149484"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Paganelli G, Magnani P, Zito F, <i>et al<\/i>. Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99m Tc] PnAO-biotin. Eur J Nucl Med 1994; 21: 314-21.","DOI":"10.1007\/BF00947966"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Schold SC Jr, Zalutsky MR, Coleman RE, <i>et al<\/i>. Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma. Invest Radiol 1993; 28: 488-96.","DOI":"10.1097\/00004424-199306000-00003"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Midwood K, Sacre S, Piccinini AM, <i>et al<\/i>. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 2009; 15: 774-80.","DOI":"10.1038\/nm.1987"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Shimojo N, Hashizume R, Kanayama K, <i>et al<\/i>. Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin \u03b1V\u03b23\/nuclear factor-\u03baB\/interleukin-6 axis. Hypertension 2015; 66: 757-66.","DOI":"10.1161\/HYPERTENSIONAHA.115.06004"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nishioka T, Onishi K, Shimojo N, <i>et al<\/i>. Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2010; 298: H1072-8.","DOI":"10.1152\/ajpheart.00255.2009"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Presta LG. Selection, design, and engineering of therapeutic antibodies. J Allergy Clin Immunol 2005; 116: 731-6.","DOI":"10.1016\/j.jaci.2005.08.003"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kobayashi N, Odaka K, Uehara T, <i>et al<\/i>. Toward in vivo imaging of heart disease using a radiolabeled single-chain Fv fragment targeting tenascin-C. Anal Chem 2011; 83: 9123-30.","DOI":"10.1021\/ac202159p"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/1\/60_17-734\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T15:07:51Z","timestamp":1605452871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/1\/60_17-734\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-734","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]}}}